Paul Murray, Swiss Re's CEO of Life & Health Reinsurance, commented on these findings in a press release, noting that GLP-1 drugs hold "significant promise to help us beat the obesity epidemic." CLICK HERE TO GET THE FOX NEWS APP "Our research underscores that the full benefit will come from going beyond medication," he wrote
For this reason, the PHQ-9 appears more suitable for rapid screening
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as lowering the risks of heart and kidney problems
Due to its NO-releasing capabilities, nebivolol has a nephroprotective action in hypertensive patients (Price et al., 2013)
Since Zepbound can already cause gastrointestinal side effects like nausea or indigestion, avoiding NSAIDs like ibuprofen can help minimize further irritation